Login · Contact

Akorn Pharmaceuticals

Akorn Investor Relations
Investor Relations
Webcast ImageWebcast
Akorn, Inc. at Morgan Stanley Global Healthcare Conference (Replay)
09/13/16 at 12:20 p.m. ET
Akorn, Inc. at Morgan Stanley Global Healthcare Conference
Tuesday, September 13, 2016 12:20 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Q3 2016 Akorn, Inc. Earnings Conference Call (Replay)
11/03/16 at 10:00 a.m. ET
Q3 2016 Akorn, Inc. Earnings Conference Call
Thursday, November 3, 2016 10:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Akorn, Inc. at Piper Jaffray 28th Annual Healthcare Conference (Replay)
11/29/16 at 8:30 a.m. ET
Akorn, Inc. at Piper Jaffray 28th Annual Healthcare Conference
Tuesday, November 29, 2016 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Akorn, Inc. is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals and branded as well as private-label over-the-counter consumer health products and animal health pharmaceuticals. Akorn is an industry leader in the development, manufacturing and marketing of generic pharmaceutical products in alternate dosage forms. The Company focuses on difficult-to-manufacture sterile and non-sterile dosage forms including, but not limited to, ophthalmics, injectables, oral liquids, otics, topicals, inhalants and nasal sprays.

In order to successfully execute its strategy, Akorn continues to capitalize on its core strengths:

Research and development expertise in alternate dosage forms. The R&D efforts are primarily focused on the development of multisource generic products that are in dosage forms other than oral solid...  More >>

Stock Quote
AKRX (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$18.94
Change (%) Stock is Down 1.28 (6.33%)
Volume3,077,314
Data as of 12/06/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Notice of Waiver to Holders - 3.50% Convertible Senior Notes due June 1, 2016
Notice of Settlement Method Election - 3.50% Convertible Senior Notes Due 2016
Recent NewsMore >>
DateTitle 
11/29/16Akorn Launches Ibuprofen Oral Suspension
LAKE FOREST, Ill., Nov. 29, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched the prescription version of Ibuprofen 100mg/5mL oral suspension in 118mL and 473mL bottles as well as 5mL unit dose cups. About Ibuprofen 100mg/5mL Oral Suspension Ibuprofen Oral Suspension, USP is a sucrose-sweetened, orange-colored, berry-flavored suspension containing 100 mg of ibuprofen in 5 mL (20 mg/mL). In Pediatric Patients,... 
Printer Friendly Version
11/28/16Akorn Invalidates Durezol® Patent Via Inter Partes Review Proceeding
LAKE FOREST, Ill., Nov. 28, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that on November 22, 2016, the Patent Trial and Appeal Board (PTAB) ruled in favor of Akorn in its inter partes review (IPR) proceeding and found all the claims of the 6,114,319 patent (“ ‘319 patent”) related to the Durezol® formulation to be obvious. The ‘319 patent, directed to emulsions of difluprednate, is owned by Senju Pharmaceutical Co., Ltd. and M... 
Printer Friendly Version
11/16/16Akorn to Present at Piper Jaffray 28th Annual Healthcare Conference
LAKE FOREST, Ill., Nov. 16, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Akorn’s Chief Financial Officer, Duane Portwood, will present at the Piper Jaffray 28th Annual Healthcare Conference. Event: Piper Jaffray 28th Annual Healthcare Conference Date: November 29, 2016 Time: 8:30 a.m. ET Location: Lotte New York Palace, New York, NY The presentation will be webcast live and available on the “Events & Pre... 
Printer Friendly Version
Latest Investor PresentationMore >>
DateTitle
11/29/16Piper Jaffray Healthcare Conference Presentation Download Documentation 
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Akorn, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.